Allergan plc. (NYSE:AGN) managed to eke out gains of 1.07% in intraday trade. The share price increased by 2.57 points to $243.5. Till last observation, the net money flow was recorded at a negative $(-11.04) million. The total inflow of $164.02 million in upticks was completely overshadowed by an outflow of $175.07 million in downticks, giving the up/down ratio a value of 0.94. The shares have seen a change of -1.4% in the past week.A block trade occurred in the company shares in which the composite value of the upticks was $10.45 million and the composite value in downticks was $19.95 million. The resultant up/down ratio for the block exchange was 0.52. The block trade had a negative money flow of $(-9.5) million.
Currently the company Insiders own 0.27% of Allergan plc. shares according to the proxy statements. In the past twelve weeks, the net percent change held by company insiders has changed by 5.85% . Institutional Investors own 86.78% of Allergan plc. shares. During last six month period, the net percent change held by insiders has seen a change of 5.85%. On the companys insider trading activities, Hilado Maria Teresa, CFO of Allergan Plc, executed a transaction worth $159,678 on June 2, 2016. A total of 661 shares were purchased at an average price of $241.57. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Allergan plc. (NYSE:AGN) : On Monday heightened volatility was witnessed in Allergan plc. (NYSE:AGN) which led to swings in the share price. The stock opened for trading at $240.05 and hit $245.725 on the upside , eventually ending the session at $243.55, with a gain of 1.09% or 2.62 points. The heightened volatility saw the trading volume jump to 2,883,757 shares. The 52-week high of the share price is $340.34 and the company has a market cap of $96,338 million. The 52-week low of the share price is at $195.5 .
Many analysts have stated their opinion on the company shares. Piper Jaffray downgrades their rating on the shares of Allergan plc. (NYSE:AGN). The current rating of the shares is Neutral. Earlier, the shares were rated a Overweight by the brokerage firm. Equity Analysts at the Firm lowers the price target to $238 per share from $311 per share. The rating by the firm was issued on April 18, 2016.